glp-1 receptor agonist contraindications for switching GLP-1 Receptor Agonists: antidiabetic and
Description
doi:10.1002/cpt.2430 7
Major adverse cardiovascular and limb events in patients with diabetes treated with GLP-1 receptor agonists vs DPP-4 inhibitors
Powell-Wiley TM, Poirier CP, Burke VCLE, Desprs JP, Gordon-Larsen P, Lavie CJ, et al
"While bioavailability may be lower with oral dissolving tablets compared to injectable formats, this can actually be advantageous for specific patient needs," said Kumar
